Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects

Am J Clin Nutr. 1999 Mar;69(3):403-10. doi: 10.1093/ajcn/69.3.403.

Abstract

Background: Full-fat sitostanol ester-containing margarine reduces serum total and LDL cholesterol, but the effect of plant stanol ester-containing margarine as part of a low-fat, low-cholesterol diet has not been studied.

Objective: We investigated the cholesterol-lowering effects of 2 novel, low-fat stanol ester-containing margarines as part of a low-fat diet recommended for hypercholesterolemic subjects.

Design: In a parallel, double-blind study, 55 hypercholesterolemic subjects were randomly assigned after a 4-wk high-fat diet (baseline) to 3 low-fat margarine groups: wood stanol ester-containing margarine (WSEM), vegetable oil stanol ester-containing margarine (VOSEM), and control margarine (no stanol esters). The groups consumed the margarines for 8 wk as part of a diet resembling that of the National Cholesterol Education Program's Step II diet. The daily mean total stanol intake was 2.31 and 2.16 g in the WSEM and VOSEM groups, respectively.

Results: During the experimental period, the reduction in serum total cholesterol was 10.6% (P < 0.001) and 8.1% (P < 0.05) greater and in LDL cholesterol was 13.7% (P < 0.01) and 8.6% (P = 0.072) greater in the WSEM and VOSEM groups, respectively, than in the control group. Serum campesterol concentrations decreased 34.5% and 41.3% (P < 0.001) in the WSEM and VOSEM groups, respectively. Serum HDL cholesterol, sitostanol, campestanol, beta-carotene, and fat-soluble vitamin concentrations did not change significantly from baseline.

Conclusions: We conclude that the low-fat, plant stanol ester-containing margarines are effective cholesterol-lowering products in hypercholesterolemic subjects when used as part of a low-fat, low-cholesterol diet. They offer an additional, clinically significant reduction in serum cholesterol concentrations to that obtained with a low-fat diet alone.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anticholesteremic Agents / administration & dosage
  • Anticholesteremic Agents / therapeutic use*
  • Antioxidants / metabolism
  • Cholesterol, HDL / blood*
  • Diet, Fat-Restricted*
  • Double-Blind Method
  • Esters / administration & dosage
  • Esters / therapeutic use
  • Female
  • Finland
  • Humans
  • Hypercholesterolemia / diet therapy*
  • Male
  • Margarine*
  • Plant Oils / administration & dosage
  • Sitosterols / administration & dosage
  • Sitosterols / therapeutic use*
  • Wood
  • beta Carotene / blood

Substances

  • Anticholesteremic Agents
  • Antioxidants
  • Cholesterol, HDL
  • Esters
  • Plant Oils
  • Sitosterols
  • beta Carotene
  • Margarine
  • stigmastanol